Product Information

ACYCLOVIR 200 MG/5 ML SUSP is a generic product labeled by Actavis Pharma, Inc., priced at $0.0820 per ML under NDC 00472008216. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Apr 28, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACYCLOVIR 200 MG/5 ML SUSP

Acyclovir
$0.0820per ML

Strength

200 mg/5mL

NDC

00472008216

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACYCLOVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA074738

FDA Approved

4/28/1997

TE Code

AB

On Market Since

9/3/2002

Price Statistics

The NADAC for ACYCLOVIR 200 MG/5 ML SUSP has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 47.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0820 per ML
All-time high$0.7648 (Oct 15, 2014)
All-time low$0.0583 (Nov 20, 2024)
52-week high$0.0832
52-week low$0.0640
Median price$0.3590
Average price$0.3450
Largest weekly change+153.5% (Aug 6, 2014)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-1.4%

1M

-1.4%

3M

+18.2%

6M

+17.1%

1Y

-0.1%

3Y

-39.4%

5Y

-67.9%

All

-47.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACYCLOVIR 200 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 200 MG/5 ML SUSP, manufactured by Actavis Pharma, Inc., is $0.0820 per ML (NDC 00472008216), effective Nov 18, 2026.

How has the price of ACYCLOVIR 200 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for ACYCLOVIR 200 MG/5 ML SUSP has declined 47.9%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACYCLOVIR 200 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for ACYCLOVIR 200 MG/5 ML SUSP has ranged from a low of $0.0583 (Nov 20, 2024) to a high of $0.7648 (Oct 15, 2014), with a median of $0.3590 per ML.

Are there cheaper alternatives to ACYCLOVIR 200 MG/5 ML SUSP?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACYCLOVIR 200 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures ACYCLOVIR 200 MG/5 ML SUSP?

ACYCLOVIR 200 MG/5 ML SUSP (NDC 00472008216) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.